Differential Diagnosis for Elevated Kappa and Lambda Light Chains

Primary Diagnostic Approach

• The American College of Physicians recommends assessing renal function first by measuring serum creatinine, eGFR, and electrolytes immediately in patients with elevated kappa and lambda light chains 1
• In patients with severe renal impairment, the normal kappa:lambda ratio can rise to 0.34-3.10, making both chains appear elevated 1
• The International Myeloma Society suggests calculating the kappa:lambda ratio to distinguish between polyclonal and monoclonal elevations 2, 1

Differential Diagnosis by Pattern

• The National Comprehensive Cancer Network recommends considering chronic kidney disease as a primary cause of polyclonal elevation of both kappa and lambda light chains 1
• Inflammatory conditions, such as those seen in patients with autoimmune diseases, can cause polyclonal B-cell activation and elevation of both light chains 3
• The European Society for Medical Oncology suggests that infections can cause reactive plasmacytosis, leading to polyclonal elevation of both light chains 4

Malignant Conditions

• The American Society of Clinical Oncology recommends considering light chain multiple myeloma in patients with abnormal FLC ratio, ≥10% clonal bone marrow plasma cells, and presence of CRAB features or myeloma-defining biomarkers 6, 1
• Primary plasma cell leukemia is characterized by ≥5% circulating plasma cells in peripheral blood, abnormal FLC ratio, and often presents with higher light chain levels 7, 1

Renal Manifestations of Monoclonal Light Chains

• The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines suggest that light chain cast nephropathy requires urgent bortezomib-based therapy 1
• Light chain deposition disease is characterized by nodular sclerosing glomerulopathy pattern, linear deposits along tubular and glomerular basement membranes, and Congo red negative staining 8, 9

Essential Diagnostic Workup

• The National Comprehensive Cancer Network recommends initial laboratory studies, including serum protein electrophoresis, immunofixation, serum free light chain assay, and 24-hour urine collection with UPEP and UIFE 6, 1
• Bone marrow evaluation, including aspirate and biopsy with plasma cell quantification, flow cytometry, and FISH for high-risk cytogenetics, is recommended if monoclonal gammopathy is suspected 6, 4

Critical Pitfalls to Avoid

• The International Myeloma Society suggests avoiding the assumption of plasma cell disorder based solely on elevated light chains without checking the ratio 6, 1
• The American Society of Clinical Oncology recommends using the same assay for serial measurements and adjusting interpretation of renal impairment accordingly 6, 1